Bright Minds Biosciences reported cash from operations of -$6.03M and free cash flow of -$6.03M for the quarter ended Jun 2026, down 338.4% year over year. This cash flow statement covers 25 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2019 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||
| Net Income | 3.85M | 3.54M | 2.09M | 1.72M | 1.52M | 1.09M | 1.14M | -1.24M | 2.93M | -0.17M | 0.57M | 0.04M | 1.99M | 3.78M | 2.97M | -5.42M | -7.63M | -1.73M | |||||||
| Share-based CompensationStock Comp. | 0.30M | 0.21M | 0.23M | 0.23M | 0.02M | 0.36M | 0.02M | 0.18M | 0.30M | 0.16M | 0.17M | 0.13M | 0.15M | 0.13M | 0.43M | 0.95M | 0.78M | 0.92M | 0.88M | 1.12M | |||||
| Cash from Restructuring | 0.02M | 0.02M | 0.02M | -0.11M | 0.02M | 0.02M | 0.02M | -0.11M | 0.02M | 0.02M | 0.02M | -0.13M | -0.02M | -0.02M | -0.02M | ||||||||||
| Cash from OperationsCash from Ops. | 1.90M | 3.93M | 2.88M | 2.24M | 1.63M | 1.96M | 1.12M | 1.23M | -9.59M | 0.60M | 0.60M | -0.18M | -2.37M | 1.07M | 1.69M | 2.53M | -11.71M | -4.17M | -6.74M | -6.03M | |||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | -0.02M | 0.05M | 0.02M | 0.02M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | ||||||||||
| Change in Working Capital | |||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 0.15M | -0.03M | -0.02M | 0.09M | -0.04M | 0.04M | 0.02M | -0.05M | 0.02M | 0.01M | 0.01M | -0.00M | -0.01M | 0.03M | -0.03M | 0.05M | -0.19M | -0.04M | 0.08M | -0.05M | |||||
| Change in Account PayablesChange Payables | |||||||||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 0.26M | 0.12M | 0.17M | -0.09M | 0.39M | -0.70M | 0.35M | 0.92M | -1.46M | 0.44M | 0.01M | -0.47M | 0.21M | -0.04M | 0.12M | -0.02M | 1.17M | -0.47M | 1.66M | -0.92M | |||||
| Investing Activities | |||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | |||||||||||||||||||||||||
| Financing Activities | |||||||||||||||||||||||||
| Other financing activitiesOther financing | 22.27M | 0.09M | 3.00M | 0.90M | -0.91M | 0.66M | -0.66M | 0.67M | 0.17M | 0.01M | 0.11M | 0.01M | 0.03M | 0.08M | |||||||||||
| Cash from Financing ActivitiesCash from Financing | -0.01M | 0.09M | 0.00M | 0.01M | 3.88M | 1.66M | -0.02M | -0.02M | -0.02M | 0.64M | -0.02M | -0.02M | -0.02M | 37.25M | 0.16M | -0.01M | 24.21M | 9.60M | 166.60M | 0.06M | |||||
| Additional items | |||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | 0.12M | 0.15M | -0.01M | 0.02M | 0.04M | 0.01M | 0.00M | 0.08M | -0.12M | -0.03M | -0.00M | 0.03M | 0.01M | 1.17M | -0.01M | -0.56M | -0.38M | -1.03M | 1.04M | 4.62M | |||||
| Change in Cash | -1.91M | 3.83M | 2.88M | 2.24M | -2.25M | -0.30M | 1.74M | 1.24M | -6.30M | 0.04M | -0.61M | 0.16M | -0.36M | 36.18M | -1.53M | -2.54M | 23.29M | 5.43M | 159.86M | -5.97M | |||||
| Beginning Cash Balance | 0.64M | 15.68M | 15.60M | 15.50M | 15.15M | 8.57M | 8.60M | 8.66M | 8.67M | 4.96M | 5.01M | 4.93M | 4.95M | 4.09M | 3.99M | 4.13M | 4.16M | 59.45M | 60.46M | 59.94M | |||||
| Free Cash FlowFCF | 1.90M | 3.93M | 2.88M | 2.24M | 1.63M | 1.96M | 1.12M | 1.23M | -9.59M | 0.60M | 0.60M | -0.18M | -2.37M | 1.07M | 1.69M | 2.53M | -11.71M | -4.17M | -6.74M | -6.03M | |||||
| Net Cash FlowNCF | 1.89M | 4.02M | 2.88M | 2.25M | 5.52M | 3.62M | 1.10M | 1.21M | -9.60M | 1.25M | 0.58M | -0.19M | -2.39M | 38.32M | 1.85M | 2.52M | 12.50M | 5.43M | 159.86M | -5.97M |